World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
32909
World Ranking
16428
National Ranking
690

Overview

Martin Kolb is affiliated with McMaster University in Canada and contributes extensively to the field of Medicine, particularly focusing on Pulmonary and Respiratory Medicine. Their research spans several specialized subfields including Physiology, Pathology and Forensic Medicine, Surgery, and Molecular Biology.

The main topics of their work encompass:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Medical Imaging and Pathology Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational and Environmental Lung Diseases
  • Systemic Sclerosis and Related Diseases
  • Pulmonary Hypertension Research and Treatments

Martin Kolb has published frequently in several prestigious venues, with numerous contributions to:

  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • Annals of the American Thoracic Society
  • Respiratory Research

Their recent papers include:

  • "Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial" (2020) published in The Lancet Respiratory Medicine
  • "Idiopathic pulmonary fibrosis: state of the art for 2023" (2023) published in European Respiratory Journal
  • "Progressive pulmonary fibrosis: an expert group consensus statement" (2022) published in European Respiratory Journal
  • "The importance of interventional timing in the bleomycin model of pulmonary fibrosis" (2020) published in European Respiratory Journal
  • "Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study" (2022) published in The Lancet Respiratory Medicine

Frequent collaborators in Martin Kolb's research include:

  • Kerri A. Johannson
  • Christopher J. Ryerson
  • H. Manganas
  • Jolene H. Fisher
  • Nasreen Khalil

Best Publications

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    Kevin R Flaherty;Athol U Wells;Kevin K Brown

  • Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Collard Hr;Ryerson Cj;Corte Tj;Jenkins G

  • The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

    Antje Moeller;Kjetil Ask;David Warburton;Jack Gauldie

  • Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

    Martin Kolb;Peter J. Margetts;Daniel C. Anthony;Fernando Pitossi

  • Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

    Lutz Wollin;Eva Wex;Alexander Pautsch;Gisela Schnapp

  • Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers

  • Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

    Antje Moeller;Sarah E. Gilpin;Kjetil Ask;Gerard Cox

  • Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis

    Philippe Bonniaud;Martin Kolb;Martin Kolb;Tom Galt;Jennifer Robertson

  • Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Athol U. Wells;Kevin R. Flaherty;Kevin K. Brown;Yoshikazu Inoue

  • An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.

    R. Gisli Jenkins;Bethany B. Moore;Rachel C. Chambers;Oliver Eickelberg

  • Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung

    Martin Kolb;Peter J. Margetts;Patricia J. Sime;Jack Gauldie

  • Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor

    Philippe Bonniaud;Peter J. Margetts;Martin Kolb;Jane Ann Schroeder

  • TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis

    Philippe Bonniaud;Peter J. Margetts;Kjetil Ask;Kathy Flanders

  • Gene Transfer of Transforming Growth Factor-β1 to the Rat Peritoneum: Effects on Membrane Function

    Peter J. Margetts;Martin Kolb;Tom Galt;Catherine M. Hoff

  • Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis

    Michael Kreuter;Svenja Ehlers-Tenenbaum;Karin Palmowski;Jacques Bruhwyler

  • Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin.

    Martin Kolb;Peter J. Margetts;T. O. M. Galt;Patricia J. Sime

  • What's in a name? That which we call IPF, by any other name would act the same.

    Athol U Wells;Kevin K Brown;Kevin R Flaherty;Martin Kolb

  • VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

    Laszlo Farkas;Daniela Farkas;Kjetil Ask;Antje Möller

  • TGF-β, Smad3 and the process of progressive fibrosis

    J. Gauldie;P. Bonniaud;P. Sime;K. Ask

Frequent Co-Authors

Jack Gauldie
Jack Gauldie McMaster University
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Toby M. Maher
Toby M. Maher University of Southern California
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Mark D. Inman
Mark D. Inman McMaster University
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Ganesh Raghu
Ganesh Raghu University of Washington
Tobias Welte
Tobias Welte University of Hannover
Athol U. Wells
Athol U. Wells Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a range of diverse healthcare careers. Many students seek alternative pathways that align with their interests and schedules. For example, nursing schools that don't require teas exams offer a more accessible route for aspiring nurses who may be concerned about standardized test requirements.

Healthcare management is another dynamic field. Program options like a healthcare administration degree online accredited let you study from anywhere, making it easier to balance education with existing work or life commitments.

If you’re already a registered nurse, advancing your career is possible through bridge programs such as adn to fnp programs, which help nurses become family nurse practitioners in a more streamlined way.

For those interested in preventive care and wellness, earning an online degree in nutrition may be a rewarding option. This field offers opportunities to work in clinical settings, public health, or private practice, empowering others to make healthier choices.

Best Scientists Citing Martin Kolb

Trending Scientists